Sang-Joon Lee
Chief Executive Officer chez HYUNDAI PHARMACEUTICAL CO., LTD.
Fortune : 4 M $ au 31/03/2024
Profil
Sang-Joon Lee is currently the President, CEO, Director, and Head of R&D at Hyundai Pharmaceutical Co., Ltd.
He is also the Chief Executive Officer at Bioinnotis.
Mr. Lee holds an MBA from the University of San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2023 | 1 351 612 ( 4,22% ) | 4 M $ | 31/03/2024 |
Postes actifs de Sang-Joon Lee
| Sociétés | Poste | Début |
|---|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 28/02/2003 |
Bioinnotis
 Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Chief Executive Officer | - |
Formation de Sang-Joon Lee
| University of San Diego | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bioinnotis
Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Commercial Services |
